Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emily Keltner"'
Publikováno v:
Proceedings of IMPRS. 5
This project was supported by the Parkview Research Center and the Student Education and Research Fellowship Program.This project was funded, in part, with support from the Indiana Clinical and Translational Sciences Institute funded, in part by UL1T
Autor:
Lisa Hollister, Msn, Rn, BS Brandon Kiley, T. Eric White, Mph Dazar Opoku, Emily Keltner, Bs, Ma, Thein Zhu, Mbbs, Face, Frcp
Publikováno v:
Proceedings of IMPRS. 2
Background and hypothesis: Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE), are serious medical conditions that affect up to 900,000 Americans yearly, accounting for up to 100,000 death
Autor:
Shauna Wagner, Michael J. Mirro, Tammy Toscos, Kris Howard, Mindy E. Flanagan, Elizabeth Meisberger, Roy Robertson Md, Emily Keltner, Carly Daley
Publikováno v:
Journal of the American College of Cardiology. 75:958
Publikováno v:
Pacing and clinical electrophysiology : PACE. 41(10)
BACKGROUND Guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF) has been challenging to achieve universally. Healthcare providers who seek to achieve optimal medical therapy frequently consi
Publikováno v:
Journal of the American College of Cardiology. 73:1321
Retrievable inferior vena cava (IVC) filter use has increased over 115% since the Food and Drug Administration (FDA) approval in 2009. Likewise, there has been a marked increase in complications related to their increased use. In 2014 the FDA, recogn
Publikováno v:
Pacing and Clinical Electrophysiology. 42:389-389
Publikováno v:
Journal of the American College of Cardiology. 69:808
Background: Use of Guideline-Directed Medical Therapy (GDMT) in patients with Heart Failure reduced Ejection Fraction (HFrEF) has been proven to reduce mortality and morbidity. The role of the Wearable Cardioverter Defibrillator (WCD) in new HFrEF pa